Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Bevifimod (PRTX-100), a highly purified variant of Staphylococcal protein A (SpA), is utilized in research on idiopathic thrombocytopenic purpura (ITP) [1] [2].
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | Inquiry | Backorder | |
| 5 mg | Inquiry | Backorder | 
| Description | Bevifimod (PRTX-100), a highly purified variant of Staphylococcal protein A (SpA), is utilized in research on idiopathic thrombocytopenic purpura (ITP) [1] [2].  | 
| In vitro | Bevifimod (PRTX-100; concentrations of 250, 25, and 2.5 ng/mL; 48-hour exposure) inhibits the phagocytosis of W632-conditioned platelets by human monocytes in peripheral blood mononuclear cells (PBMC) [1].  | 
| In vivo | Bevifimod (PRTX-100; 2.5-250 µg/kg; i.v.; biweekly over 4 weeks) normalizes platelet counts within 1-2 weeks with no mortality in mice [2].  | 
| Synonyms | PRTX-100 | 
| Cas No. | 2223113-32-2 | 
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.